In a concerning development that echoes the recent COVID-19 “vaccine” saga, pharmaceutical giant Moderna has secured a whopping $176 million from the U.S. government to fast-track the development of a new mRNA flu vaccine. This vaccine is purportedly designed to protect against both seasonal influenza and bird flu viruses currently circulating in the United States. As Moderna prepares to kick off clinical trials next year, working closely with the U.S. government’s Biomedical Advanced Research and Development Authority (BARDA), questions arise about the true motives and implications of this massive investment.
Government’s Growing Concerns
The U.S. Department of Health and Human Services (HHS) has expressed “serious concerns” about a potential health crisis stemming from an avian flu outbreak. With the virus continuing to spread among mammals, there is a so-called “looming threat” of a new pandemic “if” it manages to jump to humans. This scenario, as reported by The Telegraph, has fueled the urgency behind the government’s investment in Moderna’s new gene therapy injection, marketed as a ‘vaccine’.
However, while globalists pretend to be trying to protect the public from this “looming threat,” their actions suggest a more sinister goal. The push for viruses to jump from mammals to humans could further harm farmers and lead to the destruction of animals that form a crucial part of the human diet. This would devastate traditional farming communities and pave the way for the promotion of lab-grown meat and bugs, aligning with the globalist agenda of controlling the food supply. By undermining natural food sources, they aim to steer the population towards synthetic alternatives, thereby increasing their grip on what people consume and furthering their control over the masses. […]
– Read More: rairfoundation.com
